Determining a Clinical Optimal Dose of Elobixibat, A Novel IBAT Inhibitor, in Japanese Patients with Chronic Constipation: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study
You can manage bookmarks using lists, please log in to your user account for this.
Media type:
E-Article
Title:
Determining a Clinical Optimal Dose of Elobixibat, A Novel IBAT Inhibitor, in Japanese Patients with Chronic Constipation: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study
Contributor:
Nakajima, Atsushi;
Seki, Mitsunori
Published:
Elsevier BV, 2017
Published in:
Gastroenterology, 152 (2017) 5, Seite S48-S49